Product Information

TELMISARTAN 80 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1781 per EA under NDC 67877048430. Its NADAC has been published 363 times since Dec 4, 2019.

FDA first approved this application on Oct 30, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TELMISARTAN 80 MG TABLET

telmisartan
$0.1781per EA

Strength

80 mg/1

NDC

67877048430

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TELMISARTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA205150

FDA Approved

10/30/2015

TE Code

AB

On Market Since

6/12/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for TELMISARTAN 80 MG TABLET has been published 363 times since Dec 4, 2019, and over the history we have for it it has declined 67.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1781 per EA
All-time high$0.6664 (Mar 11, 2020)
All-time low$0.1345 (May 22, 2024)
52-week high$0.1781
52-week low$0.1473
Median price$0.2497
Average price$0.2879
Largest weekly change+53.7% (Nov 22, 2023)
Weeks tracked363
Tracking sinceDec 4, 2019

Price History

1W

0.0%

1M

+9.1%

3M

+20.8%

6M

+17.8%

1Y

+15.2%

3Y

+9.4%

5Y

-55.4%

All

-67.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TELMISARTAN 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 80 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.1781 per EA (NDC 67877048430), effective Nov 11, 2026.

How has the price of TELMISARTAN 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for TELMISARTAN 80 MG TABLET has declined 67.7%. It has been tracked across 363 weekly CMS publications since Dec 4, 2019.

What are the highest and lowest recorded NADAC prices for TELMISARTAN 80 MG TABLET?

Since Dec 4, 2019, the NADAC for TELMISARTAN 80 MG TABLET has ranged from a low of $0.1345 (May 22, 2024) to a high of $0.6664 (Mar 11, 2020), with a median of $0.2497 per EA.

Are there cheaper alternatives to TELMISARTAN 80 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN 80 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TELMISARTAN 80 MG TABLET?

TELMISARTAN 80 MG TABLET (NDC 67877048430) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.